🇺🇸 FDA
Pipeline program

anti-BCMA/CD70-CAR-T cells

PBC088

Phase 1 mab active

Quick answer

anti-BCMA/CD70-CAR-T cells for CAR T Cell Therapy is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
CAR T Cell Therapy
Phase
Phase 1
Modality
mab
Status
active

Clinical trials